Sam Waksal (Robin Marchant/Getty Images)

Sam Wak­sal's ROCK2 biotech Gravi­ton hauls in $35M boost from Ena­vate

In­vestors are pour­ing more mon­ey in­to a biotech cre­at­ed by in­dus­try vet­er­an Sam Wak­sal, founder of Im­Clone Sys­tems, Kad­mon, MeiraGTx and Équili­bre Bio­phar­ma­ceu­ti­cals, and who …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.